These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7090891)

  • 21. Pharmacogenetics of lithium response in bipolar disorder.
    Alda M
    J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early mood swings as symptoms of the bipolar prodrome: preliminary results of a retrospective analysis.
    Ozgürdal S; van Haren E; Hauser M; Ströhle A; Bauer M; Assion HJ; Juckel G
    Psychopathology; 2009; 42(5):337-42. PubMed ID: 19672137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder.
    Alda M; Grof P; Rouleau GA; Turecki G; Young LT
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1038-45. PubMed ID: 15946781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lithium: principles and rules of use].
    Pinabel F; Hardy P
    Rev Prat; 1999 Nov; 49(18):2053-9. PubMed ID: 10626495
    [No Abstract]   [Full Text] [Related]  

  • 26. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium in the prophylactic treatment of recurrent affective disorders.
    Kua EH; Lee SL; Chee KT
    Singapore Med J; 1982 Oct; 23(5):262-4. PubMed ID: 7157005
    [No Abstract]   [Full Text] [Related]  

  • 28. The long term prophylaxis of affective disorders.
    Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
    Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
    [No Abstract]   [Full Text] [Related]  

  • 29. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
    Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
    J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does lithium stabilize mood?
    DePaulo JR; Correa EI; Folstein MF
    Biol Psychiatry; 1983 Sep; 18(9):1093-7. PubMed ID: 6640006
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological factors in affective disorders and their relevance to lithium prophylaxis.
    Mendlewicz J
    Pharmacopsychiatria; 1982 Jan; 15(1):11-8. PubMed ID: 7063525
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lithium gluconate in emotional disturbances (preliminary results; current orientation)].
    Chazot G; Eyssette M; Fournis Y; Aimard G; Devic M
    J Med Lyon; 1971 Oct; 52(215):1297-300. PubMed ID: 5138965
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lithium in the psychopharmacology of affective disorders and mechanisms of its effects on cellular physiology].
    Losenkov IS; Plotnikov EV; Epimakhova EV; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(11):108-115. PubMed ID: 33340305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vanadium and affective disorders.
    Naylor GJ
    Biol Psychiatry; 1983 Jan; 18(1):103-12. PubMed ID: 6299408
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lithium and other preventive agents of affective disorders in 1983].
    Soucek K; Zvolský P
    Cesk Psychiatr; 1984 Aug; 80(4):247-51. PubMed ID: 6499034
    [No Abstract]   [Full Text] [Related]  

  • 36. Puerperal affective psychosis: is there a case for lithium prophylaxis?
    van Gent EM
    Br J Psychiatry; 1993 Apr; 162():564. PubMed ID: 8481753
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroendocrine responses as an indicator of recurrence liability in primary affective illness.
    Grof E; Brown GM; Grof P
    Br J Psychiatry; 1982 Mar; 140():320-2. PubMed ID: 7046870
    [No Abstract]   [Full Text] [Related]  

  • 38. Puerperal affective disorders and response to lithium.
    Abou-Saleh MT; Coppen A
    Br J Psychiatry; 1983 May; 142():539. PubMed ID: 6871572
    [No Abstract]   [Full Text] [Related]  

  • 39. Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?
    Alda M; Grof E; Cavazzoni P; Duffy A; Martin R; Ravindran L; Grof P
    J Affect Disord; 1997 Jul; 44(2-3):153-7. PubMed ID: 9241575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of affective illness on gene expression: implications for early and long-term prophylaxis.
    Post RM
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():452A-453A. PubMed ID: 1498913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.